Diet and the gut-lung axis in cystic fibrosis – direct & indirect links. (31st December 2023)

• Record Type: Journal Article
• Authors: McKay, Isabelle; van Dorst, Josie; Katz, Tamarah; Doumit, Michael; Prentice, Bernadette; Owens, Louisa; Belessis, Yvonne; Chuang, Sandra; Jaffe, Adam; Thomas, Torsten; Coffey, Michael; Ooi, Chee Y.
• Is Part Of: Gut microbes. Volume 15:Isuse 1(2023)
• Publication Date: 2023-12-31
• Subjects: Nutrition -- microbiome -- cystic fibrosis -- gut-lung axis -- akkermansia; Gastrointestinal system -- Microbiology -- Periodicals; Microbiology -- Periodicals; Intestine, Small -- Periodicals; 616.3
• DOI: 10.1080/19490976.2022.2156254
• Languages: English
• ISSNs: 1949-0984

Abstract

ABSTRACT: Cystic fibrosis (CF) is a multisystem, autosomal, recessive disease primarily affecting the lungs, pancreas, gastrointestinal tract, and liver. Whilst there is increasing evidence of a microbial 'gut-lung axis' in chronic respiratory conditions, there has been limited analysis of such a concept in CF. We performed a comprehensive dietary and microbiota analysis to explore the interactions between diet, gastrointestinal microbiota, respiratory microbiota, and clinical outcomes in children with CF. Our results demonstrate significant alterations in intestinal inflammation and respiratory and gastrointestinal microbiota when compared to age and gender matched children without CF. We identified correlations between the gastrointestinal and respiratory microbiota, lung function, CF pulmonary exacerbations and anthropometrics, supporting the concept of an altered gut-lung axis in children with CF. We also identified significant differences in dietary quality with CF children consuming greater relative proportions of total, saturated and trans fats, and less relative proportions of carbohydrates, wholegrains, fiber, insoluble fiber, starch, and resistant starch. Our findings position the CF diet as a potential modulator in gastrointestinal inflammation and the proposed gut-lung axial relationship in CF. The dietary intake of wholegrains, fiber and resistant starch may be protective against intestinal inflammation and should be explored as potential therapeutic adjuvants for children with CF.